BridgeMD
New treatment option for Breast Feeding
Official title Hybrid Breastfeeding Education in Late Pregnancy: Effects on Antenatal Attachment and Breastfeeding
ClinicalTrials.gov ID: NCT07478341
What this study is testing
- What it's testing
- This randomized controlled study aims to examine the effect of individualized hybrid breastfeeding education provided during late pregnancy on antenatal attachment and breastfeeding behaviors among first-time mothers. Participants will be randomly assigned to either the intervention or control group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35, women only. Healthy volunteers may be eligible.
You may be able to join if
- Aged 18-35 years,
- At 36 weeks of gestation or later,
- Experiencing their first pregnancy (primiparous),
- Having a singleton pregnancy,
- Able to read and write in Turkish and capable of communication,
You likely can't join if
- Presence of chronic physical illness or pregnancy complications (e.g., preeclampsia, gestational diabetes),
- Multiple pregnancy,
- Gestation earlier than 36 weeks,
- Inability to actively participate in the education due to communication barriers or cognitive impairment,
- Lack of access to a smartphone or the internet,
- Failure to attend any stage of the educational program or voluntary withdrawal from the study,
See the full eligibility criteria
- Aged 18-35 years,
- At 36 weeks of gestation or later,
- Experiencing their first pregnancy (primiparous),
- Having a singleton pregnancy,
- Able to read and write in Turkish and capable of communication,
- Having access to a smartphone or the internet,
- Free from any physical or mental health problems that would prevent participation in the education,
- Willing to voluntarily participate in the study and provide written informed consent.
- Presence of chronic physical illness or pregnancy complications (e.g., preeclampsia, gestational diabetes),
- Multiple pregnancy,
- Gestation earlier than 36 weeks,
- Inability to actively participate in the education due to communication barriers or cognitive impairment,
- Lack of access to a smartphone or the internet,
- Failure to attend any stage of the educational program or voluntary withdrawal from the study,
- Refusal to participate in the study or failure to sign the informed consent form.
The study team makes the final eligibility decision.
Where it's taking place
- Elbistan, Kahramanmaraş, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Elbistan, Kahramanmaraş, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.